Commentary: Moving Toward Clear, Evidence-based, and Effective State Policies for Addiction Medicine.
J Addict Med
; 16(2): 130-131, 2022.
Article
em En
| MEDLINE
| ID: mdl-34014208
ABSTRACT
State policies play a critical role in determining health care delivery, health equity, and health outcomes, but vary widely in scope, target, restrictiveness, and goals. Understanding how such policies impact health care is critical to development of evidence-based policies, but difficult in the absence of organized and standardized approaches to analysis. Development of themes and frameworks for analysis, and identification of policies supported by evidence, are important steps in moving toward more rational and aligned policies. Buprenorphine treatment for opioid use disorder provides a good example and methodological foundation. At the same time, state policies are promulgated within a larger policy, treatment, and socio-economic environment, and these influences must be considered as well.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Buprenorfina
/
Medicina do Vício
/
Transtornos Relacionados ao Uso de Opioides
Limite:
Humans
Idioma:
En
Revista:
J Addict Med
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Marrocos